Abstract
The human cerebral cortex is a vital component of brain function, but the genetic influences on cortical functional organization remain poorly understood. In this study, we used a parcellation-based approach to process resting-state and task-evoked functional magnetic resonance imaging (fMRI) from over 48,000 individuals in UK Biobank and ABCD studies. We identified 47 loci associated with functional areas and networks at rest, 15 of which also affected functional connectivity during task performance. We observed patterns of heritability and locus-specific genetic effects across different brain functional areas and networks. Our findings suggest that specific functional areas and networks share genetic influences with cognition, mental health, and major brain disorders such as Alzheimer’s disease and schizophrenia. For example, the APOE ε4 locus strongly associated with Alzheimer’s disease was particularly associated with the visual cortex in the secondary visual and default mode networks in both resting and task fMRI. This study contributes to our understanding of the genetic determinants of cerebral cortex function by analyzing biobank-scale fMRI data in high-resolution brain parcellation. Additionally, it prioritizes genetically associated fMRI traits for specific brain disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was partially supported by U.S. NIH grants MH086633 (HT.Z.) and MH116527 (TF.L. and HP.Z.). Assistance for this project was also provided by the UNC Intellectual and Developmental Disabilities Research Center (NICHD; P50 HD103573; Y.L.). HCP data were provided by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The UKB study obtained ethics approval from the North West Multicentre Research Ethics Committee (approval number: 11/NW/0382). All procedures in the ABCD study were approved by the institutional review boards at ABCD collection sites (approval numbers: 201708123 and 160091).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Update the data analysis to include more data from the UK Biobank and ABCD studies.
